BioCorRx (BICX) Depreciation & Amortization (CF) (2011 - 2026)
BioCorRx (BICX) posted Depreciation & Amortization (CF) of $11195.0 for Q1 2026, up 108.97% sequentially from -$124804.0 in Q4 2025, and down 54.94% YoY from $24843.0 in Q1 2025.
Powered by 
Analysis
BioCorRx (BICX) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
BioCorRx has reported Depreciation & Amortization (CF) for 16 years, with the latest figure at $11195.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 54.94% year-over-year to $11195.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30355.0 (down 40.8% YoY) and the FY2025 annual result came in at $44003.0, up 32.76% from the prior year.
- Depreciation & Amortization (CF) rose to $11195.0 in Q1 2026 per BICX's latest filing, from -$124804.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $71987.0 in Q3 2025 and troughed at -$124804.0 in Q4 2025.
- A 5-year average of $8388.3 and a median of $6862.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- The widest YoY moves for Depreciation & Amortization (CF): up 972.04% in 2025, down 1059.81% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $6862.0 in 2022, then decreased by 2.14% to $6715.0 in 2023, then soared by 93.64% to $13003.0 in 2024, then sank by 1059.81% to -$124804.0 in 2025, then surged by 108.97% to $11195.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $11195.0, -$124804.0, and $71987.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 944.00 Mn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 215.00 Mn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 90.40 Mn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | - |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 167.34 Mn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 31.41 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 16.99 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 19.90 Mn |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 11,195.00 |
| Jun 30, 2025 | 71,977.00 |
| Mar 31, 2025 | 24,843.00 |
| Dec 31, 2024 | 13,003.00 |
| Sep 30, 2024 | 6,715.00 |
| Jun 30, 2024 | 6,714.00 |
| Mar 31, 2024 | 6,713.00 |
| Dec 31, 2023 | 6,715.00 |
| Sep 30, 2023 | 6,714.00 |
| Jun 30, 2023 | 6,714.00 |
| Mar 31, 2023 | 6,665.00 |
| Dec 31, 2022 | 6,862.00 |
| Sep 30, 2022 | 6,863.00 |
| Jun 30, 2022 | 6,862.00 |
| Mar 31, 2022 | 6,863.00 |
| Dec 31, 2021 | 6,863.00 |
| Sep 30, 2021 | 18,747.00 |
| Jun 30, 2021 | 19,340.00 |
| Mar 31, 2021 | 19,378.00 |
| Dec 31, 2020 | 19,748.00 |